Effects of GLP-1 receptor agonists on copeptin in euvolemic participants
Our analysis provides evidence that the GLP-1-RA dulaglutide inhibits the vasopressin system and proposes physiological mechanisms that may explain the role of GLP-1 in sodium and water balance.
Authors
- Julie Celine Refardt (ORCID: https://orcid.org/0000-0002-3040-4685)
- Bettina Winzeler (ORCID: https://orcid.org/0000-0001-8305-2700)
- Clara Odilia Sailer (ORCID: https://orcid.org/0000-0001-6439-8191)
- D. Vogt (ORCID: https://orcid.org/0000-0002-0668-5675)
- Svenja Leibnitz (ORCID: https://orcid.org/0009-0000-2643-0111)
- Mirjam Christ-Crain
Institutions
- Brigham and Women's Hospital (US)
- Erasmus MC (NL)
- University Hospital of Basel (CH)
- Hospital Base (CL)
- University Hospital of Zurich (CH)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1093/ejendo/lvag005
- Primary Topic
- Electrolyte and hormonal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00